NO985325L - Anvendelse av substituert azaspiran ved behandling av astma - Google Patents

Anvendelse av substituert azaspiran ved behandling av astma

Info

Publication number
NO985325L
NO985325L NO985325A NO985325A NO985325L NO 985325 L NO985325 L NO 985325L NO 985325 A NO985325 A NO 985325A NO 985325 A NO985325 A NO 985325A NO 985325 L NO985325 L NO 985325L
Authority
NO
Norway
Prior art keywords
azaspiran
substituted
asthma
treatment
administering
Prior art date
Application number
NO985325A
Other languages
English (en)
Other versions
NO985325D0 (no
Inventor
Mary Alison Badger
John Gerald Gleason
Original Assignee
Anormed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anormed Inc filed Critical Anormed Inc
Publication of NO985325L publication Critical patent/NO985325L/no
Publication of NO985325D0 publication Critical patent/NO985325D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Fremgangsmåte for behandling av astma hos pattedyr innbefattet mennesker, som omfatter at et slikt menneske tilføres en effektiv mengde av et substituert azaspiran.
NO985325A 1996-05-17 1998-11-16 Anvendelse av substituert azaspiran ved behandling av astma NO985325D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1788996P 1996-05-17 1996-05-17
PCT/IB1997/000688 WO1997044030A1 (en) 1996-05-17 1997-05-15 Use of substituted azaspirane in the treatment of asthma

Publications (2)

Publication Number Publication Date
NO985325L true NO985325L (no) 1998-11-16
NO985325D0 NO985325D0 (no) 1998-11-16

Family

ID=21785110

Family Applications (1)

Application Number Title Priority Date Filing Date
NO985325A NO985325D0 (no) 1996-05-17 1998-11-16 Anvendelse av substituert azaspiran ved behandling av astma

Country Status (17)

Country Link
US (1) US6025364A (no)
EP (1) EP0910373A1 (no)
JP (1) JP2000513335A (no)
KR (1) KR20000010933A (no)
CN (1) CN1219129A (no)
AU (1) AU710542B2 (no)
BR (1) BR9709007A (no)
CA (1) CA2253217A1 (no)
CZ (1) CZ367598A3 (no)
HU (1) HUP0003908A3 (no)
IL (1) IL127040A0 (no)
NO (1) NO985325D0 (no)
NZ (1) NZ332627A (no)
PL (1) PL329931A1 (no)
SK (1) SK156698A3 (no)
WO (1) WO1997044030A1 (no)
ZA (1) ZA974271B (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA05009708A (es) * 2003-03-10 2006-05-25 Callisto Pharmaceuticals Inc Metodo para el tratamiento de cancer con composiciones de azaspirina.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963557A (en) * 1987-09-28 1990-10-16 Smithkline Beecham Corporation Immunomodulatory azaspiranes
EP0550595A4 (en) * 1990-09-24 1993-09-08 Smithkline Beecham Corporation Methods
ZA921120B (en) * 1991-02-19 1993-01-27 Smithkline Beecham Corp Cytokine inhibitors
US5482959A (en) * 1992-01-28 1996-01-09 Smithkline Beecham Corporation Method for delaying aids in an HIV infected individual by administration of substituted azaspirane compounds
GB9315340D0 (en) * 1993-07-23 1993-09-08 Smithkline Beecham Corp Methods
GB9315306D0 (en) * 1993-07-23 1993-09-08 Smithkline Beecham Corp Methods
GB9315351D0 (en) * 1993-07-23 1993-09-08 Smithkline Beecham Corp Methods

Also Published As

Publication number Publication date
WO1997044030A1 (en) 1997-11-27
JP2000513335A (ja) 2000-10-10
NZ332627A (en) 2001-06-29
HUP0003908A2 (en) 2001-03-28
SK156698A3 (en) 1999-06-11
CA2253217A1 (en) 1997-11-27
ZA974271B (en) 1998-08-25
PL329931A1 (en) 1999-04-26
CN1219129A (zh) 1999-06-09
BR9709007A (pt) 2000-01-04
KR20000010933A (ko) 2000-02-25
AU710542B2 (en) 1999-09-23
US6025364A (en) 2000-02-15
CZ367598A3 (cs) 1999-05-12
HUP0003908A3 (en) 2001-04-28
EP0910373A1 (en) 1999-04-28
AU2973997A (en) 1997-12-09
IL127040A0 (en) 1999-09-22
NO985325D0 (no) 1998-11-16

Similar Documents

Publication Publication Date Title
NO994256D0 (no) SmÕ molekyler som er anvendelige ved behandling av inflamasjonssykdom
BG100960A (en) Dosage forms for controlled release of azitromycin
EA199800667A1 (ru) Новые фенантридины
ES2166111T3 (es) Uso de tiagabina para el tratamiento de trastornos del sueño.
PT971713E (pt) Utilizacao de inibidores da colinesterase para tratamento de desordens da atencao
EE9700225A (et) Meetod diabetes mellituse raviks, kasutades KKF
ITRM920412A0 (it) Eteroprostanoidi, procedimento per la loro preparazione e loro impiegoterapeutico.
NO991619D0 (no) Anvendelse av en H+, K+-ATPase-inhibitor i behandlingen av nesepolypper
DE69729004D1 (de) Photodynamische therapie zur behandlung von osteosrthritis
IT1290781B1 (it) Agente attivo terapeutico per il trattamento di malattie degenerative neuronali.
DK1237562T3 (da) Fremgangsmåde til fremstilling af mikania-ekstrakter, som indeholder mikanolid og dihydromikanolid, og anvendelse i behandlingen af prolifererende sygdomme
SE9600120D0 (sv) Novel medical use
EA199800864A1 (ru) Способ лечения при боли, вызванной мигренью
NO985325L (no) Anvendelse av substituert azaspiran ved behandling av astma
NO984189L (no) FremgangsmÕte for behandling av bipolar forstyrrelse
ATE306278T1 (de) Behandlung von knochenleiden mit adrenomedullin
ID27052A (id) Pengobatan arthritis dan keadaan-keadaan lain yang sekupa
NO990436L (no) FremgangsmÕte for behandling av bipolar forstyrrelse
NO984198L (no) FremgangsmÕte for behandling av aggresjon
TR199801801T2 (xx) Madde k�t�ye kullan�m�n�n tedavisi.
NO984190L (no) FremgangsmÕte for behandling av insomnia
EA199800698A1 (ru) Способ лечения и фармацевтическая композиция
EA199800820A1 (ru) Способ лечения злоупотребления лекарственными средствами
UA25165A (uk) Спосіб оперативhого лікуваhhя косоокості по в.і. ємчеhку
UA25164A (uk) Спосіб оперативhого лікуваhhя косоокості по в.і. ємчеhку

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application